Tag Archives: USPTO

RaNA awarded first patent for blocking the interaction of long non-coding RNA with chromatin modifiers

lncRNA

CAMBRIDGE, Mass.–(BUSINESS WIRE)–RaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA, today announced that the United States Patent and Trademark office has issued the first patent covering RaNA’s transcriptional activation platform, U.S. Patent No. 9,328,346, titled “Polycomb-Associated Non-Coding RNAs.” This patent relates broadly to blocking the interaction of long non-coding RNA ...

Read More »